Rephonic
Artwork for The Lancet Infectious Diseases in conversation with

The Lancet Infectious Diseases in conversation with

The Lancet Group
Artificial Intelligence
Antimicrobial Resistance
Infectious Diseases
Oropuche Virus
Public Health
Clinical Trials
Diagnostic Systems
Tuberculosis
Pathogen Characterization
Adaptive Platform Trials
Dengue
Chikungunya Virus
Zika Virus
Nasevumab
Drug Development
Immunocompromised Patients
Infections
Data Quality
Staphylococcus Aureus Network Adaptive Platform
RSV

Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adult... more

PublishesMonthlyEpisodes121Founded5 years ago
Number of ListenersCategories
Health & FitnessScienceLife SciencesMedicine

Listen to this Podcast

Artwork for The Lancet Infectious Diseases in conversation with

Latest Episodes

Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.

They also highlight several adaptive platf... more

Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape a... more

Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and ... more

Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these tri... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Steven Tong
Infectious Diseases Physician at the Victorian Infectious Diseases Service, Royal Melbourne Hospital
Doherty Institute, University of Melbourne
Episode: In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
Joshua Davis
Infectious Diseases Physician and Clinical Trialist, School of Medicine and Public Health
University of Newcastle, Australia
Episode: In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
Jan Felix Drexler
Professor from Charité Universität Medizin in Berlin, Germany
Charité Universität Medizin
Episode: Jan Felix Drexler and Fernando Bozza on Oropouche virus
Fernando Bozza
Professor from the National Institute of Infectious Diseases, Evandro Chagas, Osvaldo Cruz Foundation, Brazil
National Institute of Infectious Diseases
Episode: Jan Felix Drexler and Fernando Bozza on Oropouche virus

Host

Saleha Hassan
Senior Editor at The Lancet Infectious Diseases, focusing on infectious disease research implications for health policy.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
Q: Can you highlight the advantages and disadvantages of adaptive platform trials compared with conventional trials?
The advantages include efficiencies in time and costs by addressing multiple questions at once. The disadvantages involve increased complexity and longer startup times.
In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
Q: Could you please explain what adaptive platform trials are and how they differ from more conventional trials?
Adaptive platform trials allow multiple questions to be addressed simultaneously within a shared infrastructure, increasing efficiency compared to conventional trials that traditionally focus on a single question.
Jan Felix Drexler and Fernando Bozza on Oropouche virus
Q: Could you please explain the data collection and design of your multi-disciplinary study?
The study involved extensive collaboration across multiple labs in Latin America and leveraged shared resources to enhance diagnostic capabilities.
Jan Felix Drexler and Fernando Bozza on Oropouche virus
Q: Could you both please provide some background information about Oropuche virus?
It's noted for being a significant vector-borne virus that historically has not been adequately documented in terms of its public health impact.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

The podcast engages listeners by offering in-depth conversations on pertinent research topics impacting public health. It covers a broad array of issues, including the management of infectious diseases, vaccination strategies, and healthcare policy developments. Each episode focuses on discussions with experts in the field, revealing the implications of their latest findings on real-world health challenges, such as COVID-19, tuberculosis, and antimicrobial resistance. With a commitment to bringing scientific discussions to a wider audience, the podcast serves as an essential resource for professionals and enthusiasts alike, shedding light on both historical contexts and emerging trends in infectious diseases.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Infectious Disease Puscast
2. The Lancet Microbe in conversation with
3. Communicable
4. NEJM This Week
5. JAMA Clinical Reviews

How many episodes of this podcast are there?

this podcast launched 5 years ago and published 121 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Steven Tong
2. Joshua Davis
3. Jan Felix Drexler
4. Fernando Bozza

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days